Related Experiment Video
Updated: Mar 24, 2026
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
947
Warfarin Anticoagulation and Spontaneous Pectoral Haematomas
Ji Can Yang1, Amgad N Makaryus2
1Hofstra Northwell School of Medicine, Department of Cardiology, North Shore University Hospital, NY, USA.
Heart, Lung & Circulation
|March 8, 2016
Summary
Warfarin, a common anticoagulant, can cause rare but serious pectoral hematomas. This study highlights three cases of spontaneous pectoral bleeding in patients on warfarin therapy.
Area of Science:
- Cardiology
- Hematology
- Pharmacology
Background:
- Warfarin is a widely prescribed oral anticoagulant for conditions like atrial fibrillation and thromboembolism.
- Major bleeding is a significant risk associated with warfarin therapy, potentially leading to life-threatening complications.
- Bleeding into enclosed spaces can be acutely fatal or cause persistent blood loss.
Observation:
- Pectoral hematomas are an uncommon manifestation of bleeding disorders.
- These hematomas are rarely documented in medical literature.
- Three cases of spontaneous pectoral hematoma developed in patients undergoing warfarin treatment were observed.
Findings:
- Patients developed spontaneous pectoral hematomas while on warfarin therapy.
- Some patients were also on heparin bridging for atrial fibrillation or thromboembolism treatment.
- These cases represent an unusual presentation of warfarin-induced bleeding diathesis.
Implications:
- Pectoral hematomas should be considered in patients on warfarin presenting with chest or pectoral swelling.
- Awareness of this rare complication is crucial for timely diagnosis and management.
- Further investigation into the mechanisms and risk factors for warfarin-induced pectoral hematomas may be warranted.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
01:29Venous Thrombosis III: Interprofessional Care
460
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
460
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
638
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
638
01:30Venous Thrombosis IV: Nursing Management
368
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
368
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
01:24Disorders of Hemostasis
2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K